Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-02-23

FDA Approved: PROCHLORPERAZINE MALEATE — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Prochlorperazine maleate by Jubilant Cadista Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PROCHLORPERAZINE MALEATE (prochlorperazine maleate)

Snippet

SUPPL AP for PROCHLORPERAZINE MALEATE (PROCHLORPERAZINE MALEATE)